Nektar Therapeutics

NKTR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000906709

SEC filings (opens in a new tab)

In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Nektar Therapeutics changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of NKTR: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	146	2	157	+13
Shares	132.9M	327.1K	123.8M	−8.76M (−6.6%)
Value	$123.6M	$304.2K	$84.2M	−$39.1M (−31.7%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Nektar Therapeutics at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to NKTR in Q1 2025
Institution	Shares	Value	% of portfolio
Union Square Park Capital Management, LLC	1,100,000	$748.0K	0.82%
Balyasny Asset Management LLC	850,115	$578.1K	0.00%
Deuterium Capital Management, LLC	560,235	$381.0K	0.85%
Fred Alger Management, LLC	506,446	$344.4K	0.00%
Gilder Gagnon Howe & Co LLC	412,379	$280.4K	0.00%
Group One Trading, L.P.	351,143	$238.8K	0.01%
Nuveen, LLC	326,716	$222.2K	0.00%
Integrated Wealth Concepts LLC	100,654	$68.4K	0.00%
49 Wealth Management, LLC	81,740	$55.6K	0.01%
Cerity Partners LLC	75,920	$51.6K	0.00%
HRT Financial LP	68,168	$46.0K	0.00%
Wealth Enhancement Advisory Services, LLC	60,371	$41.1K	0.00%
Algert Global LLC	48,700	$33.1K	0.00%
Zacks Investment Management	36,065	$24.5K	0.00%
Pallas Capital Advisors LLC	34,465	$23.4K	0.00%
Merit Financial Group, LLC	29,930	$20.4K	0.00%
HBK Sorce Advisory LLC	24,305	$16.5K	0.00%
Farringdon Capital, Ltd.	21,270	$14.5K	0.01%
Buckingham Strategic Partners	19,433	$13.2K	0.00%
Oxford Asset Management LLP	17,025	$11.6K	0.01%
Wolverine Trading, LLC	14,701	$10.9K	0.00%
Mariner, LLC	13,150	$8.94K	0.00%
Colony Group, LLC	12,922	$8.79K	0.00%
Kaufman Rossin Wealth, LLC	12,843	$8.73K	0.01%
Mercer Global Advisors Inc	11,639	$7.92K	0.00%
Coastal Bridge Advisors, LLC	10,000	$6.80K	0.00%
True Wealth Design, LLC	999	$680	0.00%
The PNC Financial Services Group, Inc.	402	$273	0.00%
Arlington Trust Co LLC	100	$68	0.00%
LRI Investments, LLC	16	$11	0.00%

Sold out (17)

Institutions that held Nektar Therapeutics at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of NKTR in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Samlyn Capital, LLC	9,667,048	$8.99M
Deep Track Capital, LP	1,975,998	$1.84M
Diadema Partners LP	698,919	$650.0K
Wellington Management Group LLP	522,409	$485.8K
Shay Capital LLC	352,204	$327.6K
Marquette Asset Management, LLC	158,809	$147.7K
Persistent Asset Partners Ltd	166,572	$137.8K
Squarepoint Ops LLC	139,758	$130.0K
Qube Research & Technologies Ltd	65,759	$61.2K
Bank of Montreal	54,500	$50.7K
Moloney Securities Asset Management, LLC	50,000	$46.5K
Harvest Investment Services, LLC	29,244	$27.2K
Two Sigma Securities, LLC	27,654	$25.7K
Neuberger Berman Group LLC	20,522	$19.1K
R Squared Ltd	3,720	$3.46K
Federated Hermes, Inc.	1,256	$1.17K
Cornerstone Planning Group LLC	5	$4

Not filed for Q1 2025 yet (2)

Institutions that held Nektar Therapeutics at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NKTR in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	326,716	$303.8K
Global Retirement Partners, LLC	416	$387